Stem cell treatment for widespread heart artery narrowing
Part of Heart & circulation clinical trials.
This study tests a new stem cell treatment for people with widespread coronary artery disease (narrowing of heart blood vessels) that causes chest pain. The treatment aims to improve blood flow and reduce symptoms, even for those who are not good candidates for other procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with diffuse coronary artery disease (widespread narrowing of heart vessels).
- You are between 20 and 80 years old.
- You are taking heart medications as prescribed.
- You have chest pain (angina) that limits some activity, even at rest (Class II–IV).
- You are not pregnant or breastfeeding, and you do not have HIV, hepatitis, or another active infection.
- You have not had a heart attack in the past 3 months, and you do not have severe valve disease or serious kidney problems (like being on dialysis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new stem cell treatment (HeXell-2020) for people with stable coronary artery disease. It aims to see if it's safe and can improve heart function. You may be eligible if you have stable angina and are on regular heart medications.
This trial tests if combining a new heart procedure with a special type of therapy called mindfulness therapy can help prevent heart problems in people with coronary artery disease that could not be fully fixed with stents or surgery.
This study checks how severely blocked a coronary artery is using measurements taken during a planned heart catheterization, to help guide whether and how to do a stent (PCI). It may help doctors choose the best treatment plan for people with about 70% or more narrowing.
This study looks at real-world outcomes for people with narrowed heart arteries (coronary artery disease). It may include those treated with stents (PCI) or medicines. Doctors will use a special computer tool to measure the severity of blockages and track health over time.
This trial tests a new device to improve the expansion of stents in heart arteries that are not fully opened. If you are having a stent placed for blocked arteries, this study may help ensure the stent works better to restore blood flow.
This study tests a new way to treat long, narrow blockages in the heart's arteries. It combines a temporary scaffold with a drug-coated balloon, which may help the artery heal without a permanent metal stent. This could be an option for people who need their artery opened but may benefit from a less permanent approach.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.